Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd cash flow quality index. Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Quality Index of 0.90x as of December 2024. Operating cash flow of CN¥24.04 Million is below net income of CN¥26.57 Million, suggesting accrual-heavy earnings not yet converted to cash. See Hunan Dajiaweikang Pharmaceutical Indust leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Cash flow quality index of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2024. Historical Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Hunan Dajiaweikang Pharmaceutical Indust debt service capacity to assess how comfortably operating cash covers total debt obligations.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Quality Index by Year (2019–2024)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For the full cash flow conversion analysis, see Hunan Dajiaweikang Pharmaceutical Indust (301126) cash conversion ratio.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.90x | CN¥24.04 Million | CN¥26.57 Million | ▲ +14.4% |
| 2023 | 0.79x | CN¥27.13 Million | CN¥34.30 Million | ▲ +108.2% |
| 2022 | -9.66x | CN¥-493.96 Million | CN¥51.12 Million | ▼ -307.6% |
| 2021 | -2.37x | CN¥-161.81 Million | CN¥68.26 Million | ▼ -1.5% |
| 2020 | -2.34x | CN¥-151.46 Million | CN¥64.85 Million | ▼ -250.6% |
| 2019 | 1.55x | CN¥135.91 Million | CN¥87.65 Million | — |